SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is capturing significant community attention as investors rally around its AI-driven infrastructure and potential for long-term utility within the Base ecosystem. Bullish sentiment is being fueled by viral discussions linking the project to high-profile AI developments, prompting active accumulation as holders look toward future growth phases.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as institutional interest builds around its Ophthalmic platform and the favorable formulary status of VEVYE, leading to strong community conviction that the company is at a historic inflection point. Investors are closely monitoring record prescription growth and sales force expansion as primary catalysts to drive the stock toward long-term targets.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is seeing a surge in investor interest driven by a significant expansion of its NFL live sports content and the broadening of its ad-supported tier to new global markets. Community members are actively debating the timing of share buybacks and whether this recent price action represents a sustainable reversal or merely a temporary relief rally.

Canary XRP ETF - Common Shares of Beneficial Interest

Canary XRP ETF

The XRP ecosystem is experiencing a surge in activity driven by optimism surrounding the CLARITY Act and significant institutional interest in spot ETFs. Investors are actively discussing the potential for increased liquidity, the role of XRP in bridging traditional and digital finance, and the impact of sustained ETF inflows on market supply.

Volatility Shares Trust - Volatility Shares Trust XRP ETF

XRP ETF

The community is heavily focused on XRP following progress with the CLARITY Act, which seeks to clarify the asset's regulatory status as a digital commodity. Investors are actively discussing the potential impact of this legislative momentum, alongside institutional integration news and the growth of XRP-linked exchange-traded products.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as investors digest the advancement of the CLARITY Act, which seeks to clarify the digital asset's regulatory status, while enthusiasm grows around the increasing institutional adoption fueled by the Bitwise XRP ETF and Ripple's expanding payment infrastructure. Community discussions are heavily focused on navigating current market volatility, analyzing long-term utility for cross-border settlements, and debating the potential impact of legislative developments on future price momentum.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

The community is actively debating the legitimacy of trending SpaceX-related tickers and crypto tokens, with many users warning that these assets are scams or unauthorized proxies capitalizing on persistent IPO rumors. Investors are expressing a mix of skepticism toward potential rug pulls and excitement over legitimate aerospace sector opportunities, while discussing the impact a future SpaceX public offering could have on the broader market.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is experiencing significant momentum as investors rotate capital into decentralized AI infrastructure, driven by institutional partnerships and a broader market focus on autonomous agent technology. The community is actively debating the project's long-term utility against market volatility, with many users focused on identifying accumulation points while weighing the potential for a larger breakout within the AI crypto narrative.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is seeing heightened market volatility and active community debate following multiple FDA rejections of its skin cancer drug, RP1. Investors are intensely focused on recent leadership changes at the agency and conflicting narratives regarding the drug's regulatory path, leading to speculative trading and heated discussions over the company's future viability.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is facing significant downward pressure as investors rotate out of SaaS stocks amid broader concerns that AI agents could disrupt the sector's traditional business models. Despite strong earnings performance and a robust cash position, the community is actively debating whether the recent sell-off is an overreaction to AI-driven fear or a justified repricing due to slowing growth and aggressive competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Catheter Precision had initially acquired a 20% stake in Flyte in February before buying out the remaining 80% earlier on Tuesday.</li><li>Creatd will receive around $6 million in cash and roughly $6 million in convertible preferred stock of VTAK, making it a significant shareholder.</li><li>Earlier this month, Catheter Precision signed an agreement to raise about $1.9 million through a private placement.</li></ul>Shares of Catheter Precision (VTAK) jumped 50% on Tuesday after the company announced it had completed the acquisition of Fly Flyte, having bought out an 80% stake from Creatd.Flyte runs regional aviation services using Cirrus Vision Jets on short-haul routes where commercial airline service is limited or unavailable. It generates revenue through aircraft equipped with advanced safety systems such as whole-aircraft parachute technology and Safe Return autonomous landing capability.<h2 class="st-heading-2">Creatd To Receive $6M In Cash, $6M In Convertible Preferred Stock</h2>As part of the transaction, Creatd will receive around $6 million in cash and roughly $6 million in convertible preferred stock of VTAK. The two companies will collaborate on developing an aviation and Electric Vertical Take-Off and Landing (eVTOL) logistics platform.The deal makes Creatd a significant shareholder in VTAK, while it continues to pursue its plan to secure a national exchange listing later this year.Catheter Precision had initially acquired a 20% stake in Flyte in February, stating that the investment provides immediate exposure to the fast-growing private aviation sector and supports an asset-backed, scalable fleet expansion model.<h2 class="st-heading-2">Fundraising Worth Around $1.9 Million</h2>Earlier this month, Catheter Precision signed a securities purchase agreement with investors to raise about $1.9 million through a private placement of Series C-1 Convertible Preferred Stock, according to an SEC filing. The shares can initially convert into up to 1.3 million common shares at a conversion price of $1.43 per share.Investors also agreed to purchase additional Series C-2 and Series C-3 convertible preferred shares. The company plans to use the proceeds for working capital, restructuring its legacy catheter business, resolving liabilities, and reducing operating expenses.This came after the company completed a strategic financing deal with institutional investors worth up to $36.5 million last month.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/VTAK">VTAK</a> on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/VTAK_jpg_6ed250b1a0.webp" alt="VTAK.jpg">One user expects the momentum to push the stock to $3 from its current price of around $2.<stembedurl>https://stocktwits.com/LosersMakeMillions/message/647117481</stembedurl>Another user said that since the revenue is “asset-backed,” it will grow when new jets are added to the service.<stembedurl>https://stocktwits.com/bachsong/message/647102061</stembedurl>VTAK shares have gained around 10% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/polymarket-pltr-stock-palantir-crackdown-insider-trading-sports-betting/cZdopaXRI7R">Polymarket Ropes In Palantir To Track Suspicious Sports Prediction Bets: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

This Nano-Cap Medical Device Stock Soared 50% Today – What’s The Aviation Connection?

Catheter Precision completed the acquisition of Fly Flyte from Creatd, giving it access to the fast-growing private aviation sector.

VTAK Stock Jumps 50% Today – What’s Driving The Super Rally?

Equity

Strategic Partnerships and Platform Plays Power New Momentum Across Tech and Healthcare

Markets open the session with strategic partnerships, infrastructure consolidation, and breakthrough technologies dominating the corporate news cycle; several companies are positioning themselves at the intersection of innovation and scalable commercialization. $INKT, $VTAK, $KBLB, $APP, $BEAT, $SGN, $STGW

Medical device company Catheter Precision, Inc. (VTAK) announced on Monday that it has received approval for its suture retention device LockeT in the United Kingdom.LockeT is intended to assist in wound closure after percutaneous venous punctures or procedures involving the insertion of a needle through the skin to access the vein, including for the insertion of catheters. LockeT <a target="_blank" rel="noopener noreferrer nofollow" href="https://feeds.issuerdirect.com/news-release.html?newsid=4827478167656712&amp;symbol=VTAK">received</a> CE Mark for European approval and distribution in May 2025, but had to obtain registration to launch sales in the U.K. CE marking indicates a product's compliance with European Union (EU) safety, health, and environmental protection standards, allowing it to be sold freely within the European Economic Area (EEA).On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/VTAK">Catheter Precision</a> jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:627/58;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_18_at_12_40_56_PM_png_d31ad45d5e.webp" alt="VTAK's Sentiment Meter and Message Volume as of 12:40 p.m. ET on Aug. 18, 2025 | Source: Stocktwits" width="627" height="58"><figcaption>VTAK's Sentiment Meter and Message Volume as of 12:40 p.m. ET on Aug. 18, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user said they are entering a short position in the stock.<stembedurl>https://stocktwits.com/athebeast/message/625634169</stembedurl>Catheter Precision said it has partnered with HC21, a U.K.-based distributor, to distribute LockeT. Fatih Ayoglu, Sales Manager EMEA and APAC, said that the device’s intuitive design and ease of deployment enable earlier discharge following cardiac procedures.“This directly supports NHS efforts to reduce waiting lists by freeing up hospital capacity and accelerating patient throughput. With the NHS recently achieving its first reduction in waiting lists in 17 years, LockeT is poised to contribute meaningfully to this momentum by helping clinicians deliver more treatments, more efficiently,” Ayoglu added.VTAK stock is down by 56% this year and by about 91% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/vanda-pharma-stock-rallies-after-federal-appeals-court-sets-aside-fda-action/chsOi7vRdXQ">Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Did Catheter Precision Stock Soar 49% Today?

The company’s product LockeT, which bagged approval in the U.K., had received CE Mark for European approval and distribution in May 2025.

Catheter Precision, Inc. engages in the design, manufacture, and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins on September 4, 2002 and is headquartered in Fort Mill, SC.

VTAK
Catheter Precision Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest VTAK News

VTAKCatheter Precision Inc.